Screening and application of cell-selective adhesion peptide for regenerative medical materials

[1] Martin D.M., Boyle F.J., Drug-eluting stents for coronary artery disease: A review, Med Eng Phys., 33, 2, pp. 148-163, (2011)

[2] Camenzind E., Steg P.G., Wijns W., Stent thrombosis late after implantation of first-generation drug-eluting stents-A cause for concern, Circulation., 115, 11, pp. 1440-1455, (2007)

[3] Daemen J., Wenaweser P., Tsuchida K., Abrecht L., Sophia V., Morger C., Kukreja N., Juni P., Sianos G., Hellige G., Domburg R.T., Hess O.M., Boersma E., Meier B., Windecker S., Serruys P.W., Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: Data from a large twoinstitutional cohort study, Lancet., 369, 9562, pp. 667-678, (2007)

[4] Shin H., Jo S., Mikos A.G., Biomimetic materials for tissue engineering, Biomaterials., 24, 24, pp. 4353-4364, (2003)

[5] Kleinman H.K., Philp D., Hoffman M.P., Role of the extracellular matrix in morphogenesis, Curr Opin Biotechnol., 14, 5, pp. 526-532, (2003)

[6] Badylak S.F., Freytes D.O., Gilbert T.W., Extracellular matrix as a biological scaffold material: Structure and function, Acta Biomaterialia., 5, 1, pp. 1-13, (2009)

[7] Pierschbacher M.D., Ruoslahti E., Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule, Nature., 309, 5963, pp. 30-33, (1984)

[8] Rodenberg E.J., Pavalko F.M., Peptides derived from fibronectin type III connecting segments promote endothelial cell adhesion but not platelet adhesion: Implications in tissue-engineered vascular grafts, Tissue Eng., 13, 11, pp. 2653-2666, (2007)

[9] Hubbell J.A., Massia S.P., Desai N.P., Drumheller P.D., Endothelial cell-selective materials for tissue engineering in the vascular graft via a new receptor, Bio-Technology., 9, 6, pp. 568-572, (1991)

[10] Frank R., Spot-synthesis-an easy technique for the positionally addressable, parallel chemical synthesis on a membrane support, Tetrahedron., 48, 42, pp. 9217-9232, (1992)

[1] Martin D.M., Boyle F.J., Drug-eluting stents for coronary artery disease: A review, Med Eng Phys., 33, 2, pp. 148-163, (2011)

[2] Camenzind E., Steg P.G., Wijns W., Stent thrombosis late after implantation of first-generation drug-eluting stents-A cause for concern, Circulation., 115, 11, pp. 1440-1455, (2007)

[3] Daemen J., Wenaweser P., Tsuchida K., Abrecht L., Sophia V., Morger C., Kukreja N., Juni P., Sianos G., Hellige G., Domburg R.T., Hess O.M., Boersma E., Meier B., Windecker S., Serruys P.W., Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: Data from a large twoinstitutional cohort study, Lancet., 369, 9562, pp. 667-678, (2007)

[4] Shin H., Jo S., Mikos A.G., Biomimetic materials for tissue engineering, Biomaterials., 24, 24, pp. 4353-4364, (2003)

[5] Kleinman H.K., Philp D., Hoffman M.P., Role of the extracellular matrix in morphogenesis, Curr Opin Biotechnol., 14, 5, pp. 526-532, (2003)

[6] Badylak S.F., Freytes D.O., Gilbert T.W., Extracellular matrix as a biological scaffold material: Structure and function, Acta Biomaterialia., 5, 1, pp. 1-13, (2009)

[7] Pierschbacher M.D., Ruoslahti E., Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule, Nature., 309, 5963, pp. 30-33, (1984)

[8] Rodenberg E.J., Pavalko F.M., Peptides derived from fibronectin type III connecting segments promote endothelial cell adhesion but not platelet adhesion: Implications in tissue-engineered vascular grafts, Tissue Eng., 13, 11, pp. 2653-2666, (2007)

[9] Hubbell J.A., Massia S.P., Desai N.P., Drumheller P.D., Endothelial cell-selective materials for tissue engineering in the vascular graft via a new receptor, Bio-Technology., 9, 6, pp. 568-572, (1991)

[10] Frank R., Spot-synthesis-an easy technique for the positionally addressable, parallel chemical synthesis on a membrane support, Tetrahedron., 48, 42, pp. 9217-9232, (1992)